Mrs. Linda E Cole, RPAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 263 Liberty St, Arcade, NY 14009 Phone: 585-492-4010 |
Angela M Potter, RPA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 401 Main St, Arcade, NY 14009 Phone: 585-492-5088 |
News Archive
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at a small but real risk of developing a new cancer, called a second primary cancer.
In a study recently published in the journal Nature Communications, scientists have mapped the interactions between SARS-CoV-2 RNA and host RNA. They have observed that the virus heavily methylates its genome using the methylation machinery of the host RNA, leading to an improvement in viral fitness.
When President Donald Trump started touting hydroxychloroquine as "one of the biggest game changers" for treating COVID-19, researchers hoped electronic health records could quickly tell them if he was on the right track.
› Verified 1 days ago